Substance Use Disorder

doi:10.1017/9781009070256.026

Chapter 25 - Substance Use Disorder

Published online by Cambridge University Press: 26 January 2024

Grace Lim

Edited by

David R. Gambling,

M. Joanne Douglas and

Grace Lim

Show author details

David R. Gambling: Affiliation:
University of California, San Diego
M. Joanne Douglas: Affiliation:
University of British Columbia, Vancouver
Grace Lim: Affiliation:
University of Pittsburgh

Book contents

Get access

Summary

Perinatal substance use disorder is a chronic medical condition affecting between 2-5% of the population, characterized by uncontrolled use of a particular substance despite harmful consequences. Substance use disorder is increasing in frequency in the United States, particularly among women of reproductive age. It is associated with increased risk for fetal-neonatal conditions such as growth restriction, fetal alcohol syndrome, and neonatal abstinence syndrome and places patients at risk for morbidity and mortality. In this chapter, several specific substances are considered in the context of pregnancy.

Keywords

substance use substance use disorders women pregnancy

Information

Type: Chapter
Information: Obstetric Anesthesia and Uncommon Disorders , pp. 413 - 420
DOI: https://doi.org/10.1017/9781009070256.026 [Opens in a new window]
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

ACOG. ACOG Committee Opinion 711: Opioid use and opioid use disorder in pregnancy. Obstet Gynecol 2017;130:e81–e94.Google Scholar

Substance Use Disorder: APA Dictionary of Psychology; 2021. https://dictionary.apa.org/substance-use-disorder [last accessed October 2, 2022].Google Scholar

National Survey on Drug Use and Health (U.S.), United States, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Center for Behavioral Health Statistics and Quality (U.S.). Results from the 2012 National Survey on Drug Use and Health: summary of national findings. Rockville (MD): Substance Abuse and Mental Health Services Administration, 2013:1 HHS publication no (SMA) 13–4795.Google Scholar

Sander, SCE, Hays, LR. Prescription opioid dependence and treatment with methadone in pregnancy. J Opioid Management 2005;1:91–97.Google Scholar

Vesga-López, O, Blanco, C, Keyes, K, et al. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 2008;65:805–815.Google Scholar

Ebrahim, SH, Gfroerer, J. Pregnancy-related substance use in the United States during 1996–1998. Obstet Gynecol 2003;101:374–379.Google Scholar

Terplan, M, Smith, EJ, Kozloski, MJ, et al. Methamphetamine use among pregnant women. Obstet Gynecol 2009;113:1285–1291.Google Scholar

Humeniuk, R, Ali, R, Babor, T, et al. A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction 2012;107:957–966.Google Scholar

McHugh, RK, Wigderson, S, Greenfield, SF. Epidemiology of substance use in reproductive-age women. Obstet Gynecol Clin North Am 2014;41:177–189.Google Scholar

O’Connor, E, Rossom, RC, Henninger, M, et al. Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the US Preventive Services Task Force. JAMA 2016;315:388–406.Google Scholar

Dennis, CL, Falah-Hassani, K, Shiri, R. Prevalence of antenatal and postnatal anxiety: systematic review and meta-analysis. Br J Psychiatry 2017;210:315–323.Google Scholar

Hanley, GE, Mintzes, B. Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance. BMC Pregnancy Childbirth 2014;14:242.Google Scholar

Riska, BS, Skurtveit, S, Furu, K, et al. Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study. Eur J Clin Pharmacol 2014;70:1367–1374.Google Scholar

Haas, M, Qu, Z, Kim, TH, et al. Perturbations in cortical development and neuronal network excitability arising from prenatal exposure to benzodiazepines in mice. Eur J Neurosci 2013;37:1584–1593.Google Scholar

El Marroun, H, White, T, Verhulst, FC, et al. Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review. Eur Child Adolesc Psychiatry 2014;23:973–992.CrossRef Google Scholar PubMed

Laegreid, L, Hagberg, G, Lundberg, A. Neurodevelopment in late infancy after prenatal exposure to benzodiazepines – a prospective study. Neuropediatrics 1992;23:60–67.Google Scholar

Lupattelli, A, Chambers, CD, Bandoli, G, et al. Association of maternal use of benzodiazepines and Z-hypnotics during pregnancy with motor and communication skills and attention-deficit/hyperactivity disorder symptoms in preschoolers. JAMA Netw Open 2019;2:e191435.Google Scholar

National Center for Biotechnology Information. PubChem Compound Summary for CID 446220, Cocaine. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Cocaine [last accessed October 2, 2022].Google Scholar

Cain, MA, Bornick, P, Whiteman, V. The maternal, fetal, and neonatal effects of cocaine exposure in pregnancy. Clin Obstet Gynecol 2013;56:124–132.Google Scholar

Wendell, AD. Overview and epidemiology of substance abuse in pregnancy. Clin Obstet Gynecol 2013;56:91–96.Google Scholar

Oei, JL, Kingsbury, A, Dhawan, A, et al. Amphetamines, the pregnant woman and her children: a review. J Perinatol 2012;32:737–747.Google Scholar

United Nations Office on Drugs and Crime. Amphetamine-type Stimulants. Available from: www.unodc.org/documents/wdr/WDR_2010/2.5_Amphetamine-type_stimulants.pdf [last accessed October 2, 2022].Google Scholar

Keating, E, Gonçalves, P, Campos, I, et al. Folic acid uptake by the human syncytiotrophoblast: interference by pharmacotherapy, drugs of abuse and pathological conditions. Reprod Toxicol 2009;28:511–520.Google Scholar

Tomášková, A, Šlamberová, R, Černá, M. Influence of prenatal methamphetamine abuse on the brain. Epigenomes 2020;4:14. https://doi.org/10.3390/epigenomes4030014 Google Scholar

Kain, ZN, Mayes, LC, Ferris, CA, et al. Cocaine-abusing parturients undergoing cesarean section. A cohort study. Anesthesiology 1996;85:1028–1035.Google Scholar

Kuczkowski, KM. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth 2003;15:382–394.Google Scholar

Gupta, AK, Greller, HA, Hoffman, RS. Beta-blockers and cocaine: still a bad idea. Arch Int Med 2010;170:1859–1860; author reply 60.Google Scholar

Goldschmidt, L, Richardson, GA, Cornelius, MD, et al. Prenatal marijuana and alcohol exposure and academic achievement at age 10. Neurotoxicol Teratol 2004;26:521–532.CrossRef Google Scholar PubMed

Lester, BM, Tronick, EZ, LaGasse, L, et al. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 2002;110:1182–1192.Google Scholar

Patrick, SW, Schumacher, RE, Benneyworth, BD, et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA 2012;307:1934–1940.Google Scholar

Eyler, EC. Chronic and acute pain and pain management for patients in methadone maintenance treatment. Am J Addict 2013;22:75–83.Google Scholar

Jones, HE, Martin, PR, Heil, SH, et al. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat 2008;35:245–259.Google Scholar

Kork, F, Kleinwachter, R, Kaufner, L, et al. [Women in labor who consume substances: significance in obstetric anesthesia.] Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie 2011;46:640–646.Google Scholar

Martin, CE, Terplan, M, Krans, EE. Pain, opioids, and pregnancy: historical context and medical management. Clin Perinatol 2019;46:833–847.Google Scholar

Ordean, A, Kahan, M, Graves, L, et al. Integrated care for pregnant women on methadone maintenance treatment. Can Fam Physician 2013;59:e462–e469.Google Scholar

Park, EM, Meltzer-Brody, S, Suzuki, J. Evaluation and management of opioid dependence in pregnancy. Psychosomatics 2012;53:424–432.Google Scholar

Smith, MV, Costello, D, Yonkers, KA. Clinical correlates of prescription opioid analgesic use in pregnancy. Matern Child Health J 2015;19:548–556.Google Scholar

Towers, CV, Katz, E, Liske, E, et al. Psychosocial background history of pregnant women with opioid use disorder: a prospective cohort study. Am J Perinatol 2020;37:924–928.Google Scholar

Mitra, S, Sinatra, RS. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology 2004;101:212–227.Google Scholar

Sporer, KA. Acute heroin overdose. Ann Intern Med 1999;130:584–590.Google Scholar

Nelson, L, Schwaner, R. Transdermal fentanyl: pharmacology and toxicology. J Med Toxicol 2009;5:230–241.Google Scholar

Peng, PW, Sandler, AN. A review of the use of fentanyl analgesia in the management of acute pain in adults. Anesthesiology 1999;90:576–599.Google Scholar

Jones, HE, Fischer, G, Heil, SH, et al. Maternal opioid treatment: human experimental research (MOTHER) – approach, issues and lessons learned. Addiction 2012;107(Suppl. 1):28–35.Google Scholar

Souzdalnitski, D, Snegovskikh, D. Analgesia for the parturient with chronic nonmalignant pain. Tech Reg Anesth Pain Manag 2014;18:166–171.Google Scholar

Wiegand, S, Stringer, E, Seashore, C, et al. 750: Buprenorphine/naloxone (B/N) and methadone (M) maintenance during pregnancy: a chart review and comparison of maternal and neonatal outcomes. Am J Obstet Gynecol 2014;210:S368–S369.Google Scholar

Wilder, CM, Winhusen, T. Pharmacological management of opioid use disorder in pregnant women. CNS Drugs 2015;29:625–636.Google Scholar

Brown, HL. Opioid management in pregnancy and postpartum. Obstet Gynecol Clin North Am 2020;47:421–427.Google Scholar

Ecker, J, Abuhamad, A, Hill, W, et al. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Am J Obstet Gynecol 2019;221:B5–B28.Google Scholar

Faitot, V, Simonpoli, A, Keita, H. Anaesthetic and analgesic considerations in drug abusing pregnant women. Ann Fr Anesth Reanim 2009;28:609–614.Google Scholar

Fultz, JM, Senay, EC. Guidelines for the management of hospitalized narcotic addicts. Ann Int Med 1975;82:815–818.Google Scholar

Goff, M, O’Connor, M. Perinatal care of women maintained on methadone. J Midwifery Womens Health 2007;52:e23–e26.Google Scholar

Gopman, S. Prenatal and postpartum care of women with substance use disorders. Obstet Gynecol Clin North Am 2014;41:213–228.Google Scholar

Harter, K. Opioid use disorder in pregnancy. Ment Health Clin 2019;9:359–372.Google Scholar

Jones, CW, Terplan, M. Pregnancy and naltrexone pharmacotherapy. Obstet Gynecol 2018;132:923–925.Google Scholar

Jones, HE, Finnegan, LP, Kaltenbach, K. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs 2012;72:747–757.Google Scholar

Jones, HE, O’Grady, K, Dahne, J, et al. Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy. Am J Drug Alcohol Abuse 2009;35:151–156.Google Scholar

Klaman, SL, Isaacs, K, Leopold, A, et al. Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: literature review to support national guidance. J Addict Med 2017;11: 178–190.Google Scholar

Kliman, L. Drug dependence and pregnancy: antenatal and intrapartum problems. Anaesth Intens Care 1990;18:358–360.Google Scholar

Ko, JY, Tong, VT, Haight, SC, et al. Obstetrician-gynecologists’ practice patterns related to opioid use during pregnancy and postpartum – United States, 2017. J Perinatol 2020;40:412–421.Google Scholar

Landau, R. Post-cesarean delivery pain. Management of the opioid-dependent patient before, during and after cesarean delivery. Int J Obstet Anesth 2019;39:105–116.Google Scholar

Ludlow, J, Christmas, T, Paech, MJ, et al. Drug abuse and dependency during pregnancy: anaesthetic issues. Anaesth Intensive Care 2007;35:881–893.Google Scholar

Lugo, RA, Satterfield, KL, Kern, SE. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother 2005;19:13–24.Google Scholar

Mahoney, K, Reich, W, Urbanek, S. Substance use disorder: prenatal, intrapartum, and postpartum care. MCN Am J Matern Child Nurs 2019;44:284–288.Google Scholar

McNicholas, LF, Holbrook, AM, O’Grady, KE, et al. Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication. Addiction 2012;107(Suppl. 1):91–97.Google Scholar

Meyer, J, Wagner, K, Benvenuto, A, et al. Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy. Obstet Gynecol 2007;110:261–266.Google Scholar

Mozurkewich, EL, Rayburn, WF. Buprenorphine and methadone for opioid addiction during pregnancy. Obstet Gynecol Clin North Am 2014;41:241–253.Google Scholar

Pan, A, Zakowski, M. Peripartum anesthetic management of the opioid-tolerant or buprenorphine/suboxone-dependent patient. Clin Obstet Gynecol 2017;60:447–458.Google Scholar

Pritham, UA, McKay, L. Safe management of chronic pain in pregnancy in an era of opioid misuse and abuse. J Obstet Gynecol Neonatal Nurs 2014;43:554–567.Google Scholar

Raymond, BL, Kook, BT, Richardson, MG. The opioid epidemic and pregnancy: implications for anesthetic care. Curr Opin Anaesthesiol 2018;31:243–250.Google Scholar

Sen, S, Arulkumar, S, Cornett, EM, et al. New pain management options for the surgical patient on methadone and buprenorphine. Curr Pain Headache Rep 2016;20:16.Google Scholar

Soens, MA, He, J, Bateman, BT. Anesthesia considerations and post-operative pain management in pregnant women with chronic opioid use. Semin Perinatol 2019;43:149–161.Google Scholar

Tran, TH, Griffin, BL, Stone, RH, et al. Methadone, buprenorphine, and naltrexone for the treatment of opioid use disorder in pregnant women. Pharmacotherapy 2017;37:824–839.Google Scholar

Wendling, AL, Garvan, C, Roussos-Ross, D, et al. Pain outcomes among patients after cesarean consuming buprenorphine or methadone and opioid-naive patients. J Clin Anesth 2020;65:109905.Google Scholar

Wong, S, Ordean, A, Kahan, M ; Society of Obstetricians and Gynecologists of Canada. SOGC clinical practice guidelines: substance use in pregnancy: No. 256, April 2011. Int J Gynaecol Obstet 2011;114:190–202.Google Scholar

Young, JL, Lockhart, EM, Baysinger, CL. Anesthetic and obstetric management of the opioid-dependent parturient. Int Anesthesiol Clin 2014;52:67–85.Google Scholar

Cassidy, B, Cyna, AM. Challenges that opioid-dependent women present to the obstetric anaesthetist. Anaesth Intensive Care 2004;32:494–501.CrossRef Google Scholar

Reddi, D, Mehta, A, Patel, N, et al. Perioperative pain management for cesarean section in the mother with severe acute on chronic pain and opioid dependence. Eur J Anaesthesiol 2013;30:178 (abstract).Google Scholar

Vilkins, AL, Bagley, SM, Hahn, KA, et al. Comparison of post-cesarean section opioid analgesic requirements in women with opioid use disorder treated with methadone or buprenorphine. J Addict Med 2017;11:397–401.Google Scholar

Parad, R, McBride, C, Garofalo, F, et al. Equivalent post-cesarean pain and analgesic requirements in women maintained on methadone versus buprenorphine during pregnancy. Am J Obstet Gynecol 2020;222:S309.Google Scholar

Meyer, M, Paranya, G, Keefer Norris, A, et al. Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy. Eur J Pain 2010;14:939–943.Google Scholar

Shainker, SA, Saia, K, Lee-Parritz, A. Opioid addiction in pregnancy. Obstet Gynecol Surv 2012;67:817–825.Google Scholar

Boyle, RK. Intra- and postoperative anaesthetic management of an opioid addict undergoing caesarean section. Anaesth Intensive Care 1991;19:276–279.Google Scholar

Jones, HE, Johnson, RE, Milio, L. Post-cesarean pain management of patients maintained on methadone or buprenorphine. Am J Addict 2006;15:258–259.Google Scholar

Ellis, JD, Cairncross, M, Struble, CA, et al. Correlates of treatment retention and opioid misuse among postpartum women in methadone treatment. J Addict Med 2019;13:153–158.Google Scholar

Vilkins, A, Wachman, EM, Bagley, SM, et al. Comparison of post-cesarean opioid analgesic requirements in methadone- and buprenorphine-maintained women. Obstet Gynecol 2016;127:107S.Google Scholar

Gannon, M, Short, V, Becker, M, et al. Doula engagement and maternal opioid use disorder (OUD): experiences of women in OUD recovery during the perinatal period. Midwifery 2021;106:103243.Google Scholar

Alexander, K, Short, V, Gannon, M, et al. Identified gaps and opportunities in perinatal healthcare delivery for women in treatment for opioid use disorder. Subst Abus 2021;42:552–558.Google Scholar

Peacock-Chambers, E, Paterno, MT, Kiely, D, et al. Engagement in perinatal outpatient services among women in recovery from opioid use disorders. Subst Abus 2021;42:1022–1029.Google Scholar

Gesterling, L, Bradford, H. Cannabis use in pregnancy: a state of the science review. J Midwifery Womens Health 2021 (online). https://doi.org/10.1111/jmwh.13293 Google Scholar

Fried, PA. Marijuana use during pregnancy: consequences for the offspring. Semin Perinatol 1991;15:280–287.Google Scholar

Varner, MW, Silver, RM, Rowland Hogue, CJ, et al. Association between stillbirth and illicit drug use and smoking during pregnancy. Obstet Gynecol 2014;123:113–125.Google Scholar

Hernandez, M, Birnbach, DJ, Van Zundert, AA. Anesthetic management of the illicit-substance-using patient. Curr Opin Anaesthesiol 2005;18:315–324.Google Scholar

Das, SK, Paria, BC, Chakraborty, I, et al. Cannabinoid ligand-receptor signaling in the mouse uterus. Proc Natl Acad Sci U S A 1995;92:4332–4336.Google Scholar

Feinshtein, V, Erez, O, Ben-Zvi, Z, et al. Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines. PeerJ 2013;1:e153.Google Scholar

Feinshtein, V, Erez, O, Ben-Zvi, Z, et al. Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study. Am J Obstet Gynecol 2013;209:573.e1–e15.Google Scholar

Houlihan, DD, Dennedy, MC, Morrison, JJ. Effects of abnormal cannabidiol on oxytocin-induced myometrial contractility. Reproduction 2010;139:783–788.Google Scholar

Davidson, EM, Raz, N, Eyal, AM. Anesthetic considerations in medical cannabis patients. Curr Opin Anaesthesiol 2020;33:832–840.Google Scholar

Figurasin, R, Maguire, NJ. 3,4-Methylenedioxy-Methamphetamine Toxicity. [Updated July 26, 2021]. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2022. Available from: www.ncbi.nlm.nih.gov/books/NBK538482 [last accessed October 2, 2022].Google Scholar

Holmes, LB. Letter: ocular malformations associated with maternal LSD usage. Arch Ophthalmol 1975;93:1061.Google Scholar

Aase, JM, Laestadius, N, Smith, DW. Children of mothers who took LSD in pregnancy. Lancet 1970;1(7663):100–101.Google Scholar

Chan, CC, Fishman, M, Egbert, PR. Multiple ocular anomalies associated with maternal LSD ingestion. Archi Ophthalmol 1978;96:282–284.Google Scholar

Strauss, AA, Modaniou, HD, Bosu, SK. Neonatal manifestations of maternal phencyclidine (PCP) abuse. Pediatrics 1981;68:550–552.Google Scholar

Eze, N, Smith, LM, LaGasse, LL, et al. School-aged outcomes following prenatal methamphetamine exposure: 7.5-year follow-up from the infant development, environment, and lifestyle study. J Pediatr 2016;170:34–38.e1.Google Scholar

Gorman, MC, Orme, KS, Nguyen, NT, et al. Outcomes in pregnancies complicated by methamphetamine use. Am J Obstet Gynecol 2014;211:429.e1–e7.Google Scholar

Wouldes, T, LaGasse, L, Sheridan, J, et al. Maternal methamphetamine use during pregnancy and child outcome: what do we know? N Z Med J 2004;117:U1180.Google Scholar

Fischer, SP, Healzer, JM, Brook, MW, et al. General anesthesia in a patient on long-term amphetamine therapy: is there cause for concern? Anesth Analg 2000;91:758–759.Google Scholar

Johnston, RR, Way, WL, Miller, RD. Alteration of anesthetic requirement by amphetamine. Anesthesiology 1972;36:357–363.Google Scholar

Demick, DS, Lee, TT, Summers, AT, et al. Kratom: a growing substance of abuse in the United States. Ann Clin Psychiatry 2020;32:275–280.Google Scholar

U.S. Food and Drug Administration. FDA and Kratom. Available from: www.fda.gov/news-events/public-health-focus/fda-and-kratom [last accessed October 2, 2022].Google Scholar

Vermaire, DJ, Skaer, D, Tippets, W. Kratom and general anesthesia: a case report and review of the literature. A&A Practice 2019;12:103–105.Google Scholar

Smid, MC, Charles, JE, Gordon, AJ, et al. Use of Kratom, an opioid-like traditional herb, in pregnancy. Obstet Gynecol 2018;132:926–928.Google Scholar

Mackay, L, Abrahams, R. Novel case of maternal and neonatal kratom dependence and withdrawal. Can Fam Physician 2018;64:121–122.Google Scholar

National Institute on Drug Abuse (NIDA). Substance abuse while pregnant and breastfeeding. Available from: www.drugabuse.gov/publications/research-reports/substance-use-in-women/substance-use-while-pregnant-breastfeeding [last accessed October 2, 2022].Google Scholar

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the HTML of this chapter is currently unknown and may be updated in the future.